Skip to main content
. 2012 Feb 1;19(1):10. doi: 10.1186/1423-0127-19-10

Table 3.

Net transport of L-glutamate by human cancer cells and rat astrocytes.

Sub-confluent cells Confluent cells

control + PDC + Sulfa control + PDC + Sulfa
AGS + 32 (± 15) + 39 (± 21) - 9.1 (± 13) - 74 (± 6.1) + 41 (± 18) - 81.2 (± 8.4)

Caco-2 + 36 (± 26) + 44 (± 18) - 4.5 (± 9.2) - 69.9 (± 9.6) + 42 (± 12) -72.6 (± 9.6)

HeLa + 27 (± 12) + 39 (± 9.8) - 7.8 (± 11) - 63.2 (± 5.8) + 47 (± 18) - 69.1 (± 5.2)

HOG + 37 (± 9.6) + 41 (± 12) - 2.3 (± 3.4) - 68.4 (± 9.4) + 52 (± 17) -71.7 (± 6.8)

HT29 + 48 (± 14) + 51 (± 7.5) - 5.4 (± 9.1) - 64.1 (± 14) + 49 (± 9.8) - 69.8 (± 5.9)

SHSY5Y + 15 (± 9.9) + 34 (± 6.4) - 13 (± 6.8) - 74 (± 1.8) + 48 (± 13) - 79.2 (± 9.4)

STTG-1 + 52 (± 24) + 62 (± 13) - 6.9 (± 3.4) + 69 (± 12) + 74 (± 9.5) - 9.1 (± 7.9)

Astrocytes - 79 (± 2.1) + 14 (± 10.9) - 82 (± 3.4) - 91.7 (± 2.7) + 21 (± 12) - 95.6 (± 9.1)

Net transport of L-glutamate was measured as explained in Materials and Methods. Results were expressed as variations of the extracellular concentration of L-glutamate after 6 h of incubation at 37°C. Initial concentration of L-glutamate in cell medium was 100 μM. Positive and negative variation values corresponded to net secretion and absorption of L-glutamate, respectively. Inhibitors used were PDC at 100 μM and sulfasalazine at 250 μM. All results were obtained from three independent experiments and were expressed as means of the variation (in μM) ± standard deviation (S.D). Values in bold are statistically different from the control values with p at least < 0.05.